Most Active Stocks

COCHINSHIP
JUBLINGREA
BSE
SCI
INDIGO
GRSE
BEL
RELIANCE
HAL
HDFCBANK
INFY
ICICIBANK
RPOWER
CDSL
MAZDOCK
ONGC
BAJFINANCE
KOTAKBANK
OIL
SBIN

Syngene International Limited

Diagnostics & Research | Healthcare

Company Overview

Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analytical chemistry; discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals; and chemical, formulation, analytical, and clinical development services, as well as commercial manufacturing and sterile fill-finish services. It also provides lead generation, preclinical development, API, and drug product development services; and clinical trial management, pharmacokinetic analysis/bioanalytical studies, biometrics and clinical data management, central lab, regulatory, medical monitoring, pharmacovigilance, and medical writing services. In addition, the company offers chemistry, biology, safety assessment, computational, and data sciences for traditional small molecule therapeutics; biologics; and specialty modalities, such as peptides, oligonucleotides, antibody-drug conjugates, and targeted degradation/stabilization. It serves pharmaceutical, biotechnology, animal health, nutrition, consumer goods, agrochemical, performance and specialty materials, and other companies. The company has collaborations with Bristol-Myers Squibb, Baxter Inc., and Amgen Inc. The company was incorporated in 1993 and is headquartered in Bengaluru, India. Syngene International Limited is a subsidiary of Biocon Limited.

Key Information

Market Cap

266191388672

Current Price

662.55

52 Week Range

599.55 - 960.6

Previous Close

658.2

Open

659.9

Industry

Diagnostics & Research

Sector

Healthcare

Contact Details

Address

Velankani Technology Park, Block II, First Floor Electronic City Phase I, Bengaluru, 560100, India

Phone

+91-80689-19191

Website

https://www.syngeneintl.com

Financials

Day Low

657.3

Day High

664.0

Dividend Yield

0.19

PE Ratio

53.561035

Earnings Per Share

12.37

Beta

0.153

EBITDA

10437000192

Book Value

117.59

EPS

10.89218

Company Officers

Name Title Age Year Born
Mr. Peter James Jonathan Bains CEO & MD 67 1957
Mr. Deepak Jain Chief Financial Officer - -
Dr. Jayashree Aiyar Ph.D. Chief Scientific Officer - -
Krishnan G Head of Investor Relations - -
Ms. Priyadarshini Mahapatra C.S. Head of Legal, Company Secretary & Compliance Officer - -
Mr. Sandeep Nair Head of Corporate Communications - -
Mr. Andrew Webster Chief Human Resources Officer - -
Dr. Dhananjay Patankar Head of Pharmaceutical & Biopharmaceutical Development - -
Mr. Purushottam Shashikant Singnurkar Head of Formulations Development - -
Mr. Ajit Manocha Head of IT - -

Company Details

Stock History

Explore More Stocks